Risk of recurrent stroke and antiplatelet choice in breakthrough stroke while on aspirin

Uncertainty regarding an optimal antiplatelet regimen still exists in patients with breakthrough acute ischemic stroke (AIS) while on aspirin. This study provides an analysis of a prospective multicenter registry between April 2008 and April 2014. Eligible patients were on aspirin at the time of AIS...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Sci Rep
Auteurs principaux: Kim, Joon-Tae, Kim, Beom Joon, Park, Jong-Moo, Lee, Soo Joo, Cha, Jae-Kwan, Park, Tai Hwan, Lee, Kyung Bok, Lee, Jun, Hong, Keun-Sik, Lee, Byung-Chul, Kim, Dong-Eog, Choi, Jay Chol, Kwon, Jee-Hyun, Shin, Dong-Ick, Sohn, Sung Il, Lee, Ji Sung, Lee, Juneyoung, Bae, Hee-Joon
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group UK 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7541489/
https://ncbi.nlm.nih.gov/pubmed/33028887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-73836-0
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires